Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/18/1998CN1037773C Heteroatoms-containing tricyclic compounds
03/18/1998CN1037770C Method for preparing substituted thiazolyl and substituted pyridinyl derivatives
03/18/1998CN1037765C 脱氢方法 Dehydrogenation process
03/17/1998US5728885 Forming free base by reacting with caustic soda, salt forming and precipitating with tartaric acid, releasing free base from tartrate salt by caustic soda, forming salt, releasing free base, reacting with diisobutylaluminum hydrate
03/17/1998US5728874 Anti-HIV achiral polyurea oligomers, a process for creating them, formulations using them, and their use in the treatment of AIDS
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
03/17/1998US5728849 Antitumor and antileukemic agents
03/17/1998US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
03/17/1998US5728845 Immunotherapeutic nitriles
03/17/1998US5728844 Immunotherapeutic agents
03/17/1998US5728842 Angiotensin ii receptor antagonist
03/17/1998US5728835 Substituted cyclic amine compound, production process thereof and pharmaceutical composition for circulatory organ use containing the same
03/17/1998US5728830 Piperazinedione derivative antitumor agent
03/17/1998US5728829 Multistage reaction of n-protected benzotriazolyl glycine derivative with aminoketone, then reaction with ammonia and acid catalyzed cyclization
03/17/1998US5728826 Silation of pregnadienes, fractional crystallization to separate enantiomers
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728739 Ligands with affinity for retinoic acid receptors in synergistic combination with a fatty acid, treatment of diabetes, cardiovascular disease, atherosclerosis
03/17/1998US5728738 Mixing alkali with sodium mercaptoethylsulfonate
03/17/1998US5728736 Applying an arginase inhibitor to the skin
03/17/1998US5728735 Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
03/17/1998US5728733 Skin disorders, exfoliation
03/17/1998US5728731 Administering a polyamide oligomer to a patient to treat a herpes viral infection
03/17/1998US5728728 Administering felbamate to human having sepsis, hiv dementia, meningitis or central nervous system vasculitis, which is a neuronal cell protecting antagonist of glycine site of n-methyl-d-aspartate receptor complex
03/17/1998US5728727 Antiosteoporotic compound
03/17/1998US5728726 Method and compositions for inhibiting protein kinases
03/17/1998US5728724 Treatment of postmenopause syndrome, osteoporosis, cardiovascular disorders and estrogen dependent cancer
03/17/1998US5728721 N-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide, n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide
03/17/1998US5728720 Isoxazolidinedione compounds and use thereof
03/17/1998US5728719 Systemic control of parasites
03/17/1998US5728718 Retroviral protease inhibitor; treatment of htlv
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728714 Method for treating hair loss using tempo
03/17/1998US5728713 Use of quinoline-3-carboxamide compounds
03/17/1998US5728711 Antiulcer agents
03/17/1998US5728710 Rapamycin derivatives
03/17/1998US5728708 Pharmacologically active pyridine derivatives and processes for the preparation thereof
03/17/1998US5728707 Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
03/17/1998US5728705 Method of inducing vasorelaxation to treat pulmonary hypertension
03/17/1998US5728704 Substituted pyridmidines for control of diabetic complications
03/17/1998US5728703 Administering a tricyclic compound to inhibit farnesyl protein transferase
03/17/1998US5728702 Bronchodilator agents, antiallergens or antiplatelet druggs
03/17/1998US5728700 Sulfonamide compounds of azolones anti-helicobacter agents
03/17/1998US5728697 N,N-di(aryl) cyclic urea derivatives as anti-coagulants
03/17/1998US5728695 Tachykinin antagonists useful in treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/17/1998US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors
03/17/1998US5728687 Antitumour compositions containing taxane derivatives
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728685 Selectin receptors for inflammation modulators
03/17/1998US5728684 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
03/17/1998US5728683 Whitening effect
03/17/1998US5728678 Method and composition for providing nutrition to a renal failure patient
03/17/1998US5728564 U-PA mutants resistant to inhibition by their cognate inhibitors
03/17/1998US5728536 Jak kinases and regulation of Cytokine signal transduction
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728405 Method for preventing keratocyte loss
03/17/1998US5728402 Controlled release formulation of captopril or a prodrug of captopril
03/17/1998US5728401 Effervescent ranitidine formulations
03/17/1998US5728393 Cosmetic slimming by inhibiting glucose uptake
03/17/1998US5728392 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
03/17/1998US5728391 Hyaluronic acid and its salt for treating skin diseases
03/17/1998US5728378 Antitumor and antivirus agents
03/17/1998US5728375 Method for treating amyloidosis
03/17/1998US5728373 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates
03/17/1998US5728370 Long half-life for magnetic resonance imaging
03/17/1998US5727570 Method of treating hyperlipidemia in humans
03/17/1998CA2214426A1 Use in a composition of at least one pyrimidine 3-oxide derivative, 6-substituted, as a tyrosinase stimulator
03/17/1998CA1339740C Alpha-glucosidase inhibitors
03/17/1998CA1339739C Cephem compounds and processes for preparation thereof
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/16/1998CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels
03/16/1998CA2196727A1 Cyclin dependent kinase inhibitor p27kip1 and method for decreasing adhesion-dependent resistance of tumor cells to anticancer agents
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009978A1 6-o-substituted ketolides having antibacterial activity
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009975A1 1,3-dicarboxylic germanium complex and its therapeutic use
03/12/1998WO1998009971A1 25-methylene and 24,25-epoxy marcfortines and paraherquamides
03/12/1998WO1998009970A2 Alkylated rapamycin derivatives
03/12/1998WO1998009969A1 Novel aryl-pyridazines
03/12/1998WO1998009965A1 NOVEL β-LACTAM COMPOUNDS AND PROCESS FOR PREPARING THE SAME
03/12/1998WO1998009963A1 Amorphous paroxetine composition
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009953A2 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
03/12/1998WO1998009952A1 Methods of making hiv-protease inhibitors and intermediates for making them
03/12/1998WO1998009949A1 Novel acetamide derivatives and protease inhibitors
03/12/1998WO1998009948A2 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998WO1998009946A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009938A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009668A2 Use of amphiphiles as phosphatidyl choline synthesis inhibitors
03/12/1998WO1998009665A2 Iontophoretic method of using phenylephrine to improve the effect of local anesthetics
03/12/1998WO1998009654A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta
03/12/1998WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms
03/12/1998WO1998009652A1 COMPOSITION, ANTIMICROBIAL AGENT, INFECTION PREVENTIVE, AND FOOD AGAINST $i(HELICOBACTER PYLORI)
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009636A1 Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
03/12/1998WO1998009634A1 Nad or nadp containing pharmaceutical compositions for treating aids
1 ... 6679 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 6698 6699 ... 7860